Intellectual Property Related Generic Defense Strategies in the European Pharmaceutical Market

Dr. Marc P. Philipp

doi:10.5771/9783845231037

Summary

Das Buch wertet die Untersuchung des Arzneimittelsektors der Europäischen Kommission aus. Im Mittelpunkt dieser Untersuchung stehen die Praktiken der Pharmaunternehmen, den Wettbewerb durch Generika und die Entwicklung konkurrierender Originalpräparate zu verhindern bzw. zu erschweren. Die interdisziplinäre Arbeit gibt den Entscheidungsträgern der Pharmaindustrie wertvolle Hinweise welche Auswirkungen die Untersuchung hat.

Search publication

Bibliographic data

Copyright year: 2011
ISBN-Print: 978-3-8329-6707-9
ISBN-Online: 978-3-8452-3103-7
Publisher: Nomos, Baden-Baden
Series: Munich Intellectual Property Law Center - MIPLC Studies
Volume: 11
Language: English
Pages: 92
Product type: Book Titles

Titelei/InhaltsverzeichnisPages 2 - 8 Download chapter (PDF)
List of FiguresPages 9 - 10 Download chapter (PDF)
1. Research Objective and RelevancePages 11 - 14 Download chapter (PDF)
2. Research Methodology and ScopePages 14 - 16 Download chapter (PDF)
1. 1. Conflicting Healthcare Policy ObjectivesPages 17 - 19 Download chapter (PDF)
  2. Legal Protection of Pharmaceutical ProductsPages 19 - 22 Download chapter (PDF)
2. 1. Legal Basis and General Art. 102 TFEU PrinciplesPages 22 - 25 Download chapter (PDF)
  2. The Intersection of IP and Competition LawPages 25 - 27 Download chapter (PDF)
  3. The ‘More Economic Approach’ to EU Competition LawPages 27 - 28 Download chapter (PDF)
  4. The Sector Inquiry as an EU Competition Law InstrumentPages 28 - 30 Download chapter (PDF)
1. 1. Market RelevancePages 31 - 32 Download chapter (PDF)
  2. Originator Pharmaceutical CompaniesPages 32 - 34 Download chapter (PDF)
  3. Generic Pharmaceutical CompaniesPages 34 - 36 Download chapter (PDF)
2. 1. Dynamic Competition for Substitution by InnovationPages 36 - 38 Download chapter (PDF)
  2. Static Competition for Imitation of In-Market ProductsPages 38 - 41 Download chapter (PDF)
3. 1. Key Drivers for Generic EntryPages 41 - 42 Download chapter (PDF)
  2. Timing of Generic EntryPages 42 - 43 Download chapter (PDF)
1. Causalities, the PACE Framework and Cumulative Use of PracticesPages 44 - 46 Download chapter (PDF)
2. 1. Restriction of the Freedom to Operate Through Blocking/Defensive PatentingPages 46 - 51 Download chapter (PDF)
  2. Download chapter (PDF)
    1. Patent Thickets
    2. Patent-Related Disputes and Litigation
    3. Implications from Future Patent System Reforms
  3. Download chapter (PDF)
    1. Revitalization through Follow-On Innovation
    2. Authorized Generic Entry and Dispute Settlement Agreements
    3. Intervention into Generic Marketing Authorization
1. 1. Disentanglement of the Value ChainPages 71 - 73 Download chapter (PDF)
  2. Product Portfolio Shift Towards ‘Nichebuster’Pages 73 - 75 Download chapter (PDF)
2. 1. Horizontal ScalabilityPages 75 - 76 Download chapter (PDF)
  2. Business Model ConvergencePages 76 - 77 Download chapter (PDF)
Conclusion & Managerial RecommendationPages 78 - 82 Download chapter (PDF)
ReferencesPages 83 - 92 Download chapter (PDF)